Previous Article | Next Article 
Infection and Immunity, July 2001, p. 4695-4697, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4695-4697.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Hyphae and Yeasts of Candida
albicans Differentially Regulate Interleukin-12 Production by
Human Blood Monocytes: Inhibitory Role of C.
albicans Germination
Liming
Liu,1,2
Kefei
Kang,1,2,*
Masakazu
Takahara,2
Kevin D.
Cooper,2,3 and
Mahmoud A.
Ghannoum1,2,3
The Center for Medical
Mycology,1 Department of
Dermatology,2 Case Western Reserve
University and University Hospitals of Cleveland, and VA
Medical Center,3 Cleveland, Ohio
Received 27 December 2000/Returned for modification 25 February
2001/Accepted 2 April 2001
 |
ABSTRACT |
The role of Candida albicans yeast-to-hypha
transition in interleukin-12 (IL-12) production by monocytes was
investigated. Germinating C. albicans not only failed to
induce IL-12 p70 but also suppressed IL-12 production induced by
heat-killed C. albicans. Comparison of the abilities of
germinating C. albicans and agerminating mutants to
inhibit IL-12 production showed that germination of C.
albicans plays a critical role in the inhibition of IL-12 production.
 |
TEXT |
Candida albicans is a
pleiomorphic microorganism. The yeast-to-hypha transition has been
shown to be one of several virulence attributes that enable C. albicans to invade human tissues (1). Therefore,
studies aimed at determining whether candidal morphology impacts host
defense mechanisms are prudent.
Previously, we showed that the most pathogenic C. albicans
relative to Candida krusei has the ability to create an
environment rich in interleukin-10 (IL-10) and poor in IL-12 and gamma
interferon (12). Furthermore, the fact that C. krusei and heat-killed C. albicans lack the ability to
germinate raised the question of whether the interaction of monocytes
(MN) with germinating C. albicans may differentially induce
IL-12 production, leading to initiation of different types of immune responses.
In the present study, isogenic strains of C. albicans that
differ only in the ability to produce hyphae were used to explore the
role of hyphae versus that of the yeast form in IL-12 production by MN. SC 5314 is a wild-type strain of C. albicans
(5), and isogenic strain HLC54 (with deletions of the
EFG1 and CPH1 genes, which are involved in
C. albicans germination) was derived from SC 5314 (6), while HLC84 is a revertant strain of HLC54 to which
the EFG1 gene was reintroduced, thereby restoring the
ability to germinate (10). HLC54 and HLC84 were generously
provided by J. Kohler (The Whitehead Institute). Live organisms
and heat-killed C. albicans were prepared as previously
described (12).
MN were prepared from fresh normal peripheral blood with a MACS
separation column (Miltenyi Biotec, Auburn, Calif.), and the purity of
the MN was >90%. MN (2 × 106 cells) or MN
with heat-killed C. albicans at a C. albicans-to-MN ratio of 1:2 in the plates were incubated at 37°C
in a 5% CO2 incubator for 2 h. Live
C. albicans was added to activated MN at different ratios
and incubated further for 20 h, and then supernatants were
collected and stored at
70°C until use. In all experiments, the
level of endotoxin was less than 0.06 U/ml, as determined by an
E-TOXATE kit (Sigma). For the assay of the viability of MN cocultured
with C. albicans, a LIVE/DEAD Viability/Cytotoxicity kit
(Molecular Probes, Inc., Eugene, Oreg.) was employed by following the
manufacturer's instructions.
The levels of IL-12 p70 in culture supernatants were determined in
duplicate by enzyme-linked immunosorbent assay using a pair of mouse
anti-human IL-12 p70 monoclonal antibodies (Endogen, Cambridge, Mass.).
The total RNA of MN was extracted with an RNeasy total RNA kit (Qiagen,
Chatsworth, Calif.), and reverse transcription (RT)-PCR was performed
as previously described (4).
We first compared C. albicans and Saccharomyces
cerevisiae since they represent pathogenic and nonpathogenic
yeasts, respectively. More importantly, C. albicans appears
as both the yeast form and hyphae while S. cerevisiae
maintains yeast morphology under experimental conditions. After
20 h of incubation with MN, SC5314 failed to induce IL-12 p70
production (23 ± 7 pg/ml, n = 7) while S. cerevisiae strongly induced IL-12 production (162 ± 41 pg/ml, n = 3). These results confirm our previous
observation (12) that the yeast form of fungi induced
monocytic IL-12 p70 production but live, filament-forming C. albicans did not.
We further exposed MN to heat-killed C. albicans for 2 h to induce IL-12 production and also exposed MN to different
concentrations of live C. albicans. As shown in Fig.
1, heat-killed C. albicans, at
the optimal 1:2 ratio of C. albicans to MN
(12), induced high levels of IL-12 (222 ± 41 pg/ml,
n = 10). Adding live C. albicans, at a 3:10
ratio of C. albicans to MN, to the activated MN resulted in
statistically significant inhibition of IL-12 p70 production
(P < 0.01). These results showed that live C. albicans suppressed induced IL-12 p70 production by MN and did so
in a dose-dependent manner.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
Live C. albicans (L-CA)
inhibits heat-killed (HK) C. albicans-induced IL-12
production by MN. IL-12 p70 levels are expressed as means ± the
standard errors of the means. The ratios 1:10 and 3:10 represent the
C. albicans-to-MN ratios used. n = 4 to 10.
|
|
To rule out the killing of MN by C. albicans during
coculturing, the viability of MN exposed to live C. albicans
was determined (Fig. 2). Our data
indicate that the inhibition of IL-12 p70 production by C. albicans at a ratio of 3:10 was due to C. albicans-associated factors and not to killing of MN by C. albicans.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 2.
Viability of monocytes cocultured with different ratios
of C. albicans (CA). Fluorescence
intensity represents MN viability as determined by cytofluorometer. The
ratios 1:10, 3:10, and 1:2 represent the C.
albicans-to-MN ratios used. n = 2.
|
|
We next used a set of isogenic C. albicans strains, as
mentioned above, to compare their abilities to induce IL-12 production. As shown in Fig. 3A, SC5314 inhibited
(20 ± 8 pg/ml) while HLC54 strongly induced IL-12 p70 production
(216 ± 40 pg/ml). The differences in the levels of IL-12 between
SC5314 and HLC54 were statistically significant (P < 0.01). RT-PCR was performed to determine whether IL-12 p70 protein
production is mirrored at the mRNA level. As shown in Fig. 3B, the
pattern of IL-12 p40 mRNA expression paralleled IL-12 p70 protein
production following stimulation with wild-type and agerminating mutant
C. albicans. Although there is a trend toward a lower level
of IL-12 protein production by HLC54, there is no statistically
significant difference. Thus, there might be a weak case for
translational inhibition. We further used heat-killed C. albicans to induce IL-12 production by MN and then added SC5314 and HLC54 to study the IL-12-inhibitory effect of C. albicans. As shown in Fig. 4, SC5314
but not HLC54, at a 3:10 ratio of C. albicans to MN,
significantly inhibited the induction of IL-12 p70 (84 ± 22 and
331 ± 36 pg/ml for SC5314 and HLC54, respectively; P < 0.01). These results indicated that the
germinating parental strain (SC5314) significantly inhibited IL-12
production by MN while the hypha-deficient strain (HLC54) did not. To
further confirm that germination is important for IL-12 inhibition, we
performed experiments with revertant strain HLC84. Our results showed
that IL-12 p70 was significantly reinhibited by HLC84 (223 ± 16 pg/ml) relative to HLC54 (331 ± 36 pg/ml) (P < 0.05). Similarly, IL-12 p40 mRNA was associated with IL-12 protein
production by MN stimulated with C. albicans (Fig. 4B).
These results are consistent with our contention that germination of
C. albicans plays a critical role in inhibition of IL-12
production by MN.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 3.
C. albicans (CA) hyphae and blastospores
differentially induce IL-12 production by MN. (A) IL-12 p70 levels in
supernatants were measured by enzyme-linked immunosorbent assay.
n = 2 to 6. (B) RT-PCR for IL-12 p40 mRNA
expression by MN. The data shown represent three experiments with
similar results. Refer to the text for a description of the
Candida strains used. HK-CA, heat-killed
C. albicans.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 4.
Inhibition of induced IL-12 production by C.
albicans. (A) IL-12 p70 levels are expressed as means ± the standard errors of the means. n = 3 to 9. (B)
RT-PCR for IL-12 p40 mRNA expression by MN. HK-CA, heat-killed
C. albicans.
|
|
The mechanism underlying C. albicans regulation of IL-12
production by MN is not known. Recent findings showed that C. albicans hyphae as a ligand can bind to the integrin CR3
(CD11b/CD18) on MN (3). Similarly, our findings and
observations by others indicated that iC3b and Histoplasma
capsulatum as natural ligands binding to CR3 can specifically
downregulate IL-12 secretion by MN in vitro (7, 8, 13).
Thus, similar mechanisms may be operational in IL-12 inhibition by
C. albicans. Another possibility is the presence of soluble
factors released by C. albicans. For example, mannoproteins,
a water-soluble component of the C. albicans cell wall, have
been reported to exert significant immunosuppressive activity both in
vivo and in vitro (2, 11). In this regard, the culture
supernatant of C. albicans inhibited nitric oxide production
by activated macrophages and nitric oxide is known to induce IL-12 gene
expression (9). This supports our findings that IL-12
production by MN is suppressed by C. albicans. An
understanding of how C. albicans hyphae are involved in
altering host immune responses may stimulate the
development of novel immunorelated therapies for the treatment of candidiasis.
 |
ACKNOWLEDGMENTS |
This work was supported in part by a pilot and feasibility grant
(M.A.G., K.K.) from the Skin Diseases Research Center, by the National
Institutes of Health (NIAMS 2P30AR39750, AI 35097-04 [M.A.G.],
AI-41766 [K.D.C.]), and by the University Hospitals of Cleveland
Research and Education Fund.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Dermatology, Case Western Reserve University and University Hospitals of Cleveland, 11100 Euclid Ave. Rd., Cleveland, OH 44106. Phone: (216)
368-0234. Fax: (216) 368-0212. E-mail: kxk9{at}po.cwru.edu.
Editor:
T. R. Kozel
 |
REFERENCES |
| 1.
|
Brown, A. J., and N. A. Gow.
1999.
Regulatory networks controlling Candida albicans morphogenesis.
Trends Microbiol.
7:333-338[CrossRef][Medline].
|
| 2.
|
Chaffin, W. L.,
J. L. Lopez-Ribot,
M. Casanova,
D. Gozalbo, and J. P. Martinez.
1998.
Cell wall and secreted proteins of Candida albicans: identification, function, and expression.
Microbiol. Mol. Biol. Rev.
62:130-180[Abstract/Free Full Text].
|
| 3.
|
Forsyth, C. B.,
E. F. Plow, and L. Zhang.
1998.
Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CED18 subunit.
J. Immunol.
161:6198-6205[Abstract/Free Full Text].
|
| 4.
|
Kang, K.,
C. Hammerberg,
L. Meunier, and K. D. Cooper.
1994.
CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein.
J. Immunol.
153:5256-5264[Abstract].
|
| 5.
|
Leidich, S. D.,
A. S. Ibrahim,
Y. Fu,
A. Koul,
C. Jessup,
J. Vitullo,
W. Fonzi,
F. Mirbod,
N. Shigeru,
Y. Nozawa, and M. A. Ghannoum.
1998.
Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans.
J. Biol. Chem.
273:26078-26086[Abstract/Free Full Text].
|
| 6.
|
Lo, H. J.,
J. R. Kohler,
B. DiDomenico,
D. Loebenberg,
A. Cacciapuoti, and G. R. Fink.
1997.
Nonfilamentous C. albicans mutants are avirulent.
Cell
90:939-949[CrossRef][Medline].
|
| 7.
|
Marth, T., and B. L. Kelsall.
1997.
Regulation of interleukin-12 by complement receptor 3 signaling.
J. Exp. Med.
185:1987-1995[Abstract/Free Full Text].
|
| 8.
|
Mosser, D. M., and C. L. Karp.
1999.
Receptor mediated subversion of macrophage cytokine production by intracellular pathogens.
Curr. Opin. Immunol.
11:406-411[CrossRef][Medline].
|
| 9.
|
Rothe, H.,
B. Hartmann,
P. Geerlings, and H. Kolb.
1996.
Interleukin-12 gene-expression of macrophages is regulated by nitric oxide.
Biochem. Biophys. Res. Commun.
224:159-163[CrossRef][Medline].
|
| 10.
|
Stoldt, V. R.,
A. Sonneborn,
C. E. Leuker, and J. F. Ernst.
1997.
Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi.
EMBO J.
16:1982-1991[CrossRef][Medline].
|
| 11.
|
Szabo, I.,
L. Guan, and T. J. Rogers.
1995.
Modulation of macrophage phagocytic activity by cell wall components of Candida albicans.
Cell. Immunol.
164:182-188[CrossRef][Medline].
|
| 12.
|
Xiong, J.,
K. Kang,
L. Liu,
Y. Yoshida,
K. D. Cooper, and M. A. Ghannoum.
2000.
Candida albicans and Candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production.
Infect. Immun.
68:2464-2469[Abstract/Free Full Text].
|
| 13.
|
Yoshida, Y.,
K. Kang,
M. Berger,
G. Chen,
A. C. Gilliam,
A. Moser,
L. Wu,
C. Hammerberg, and K. D. Cooper.
1998.
Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin.
J. Immunol.
161:5873-5879[Abstract/Free Full Text].
|
Infection and Immunity, July 2001, p. 4695-4697, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4695-4697.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
van der Graaf, C. A. A., Netea, M. G., Verschueren, I., van der Meer, J. W. M., Kullberg, B. J.
(2005). Differential Cytokine Production and Toll-Like Receptor Signaling Pathways by Candida albicans Blastoconidia and Hyphae. Infect. Immun.
73: 7458-7464
[Abstract]
[Full Text]
-
Tang, N., Liu, L., Kang, K., Mukherjee, P. K., Takahara, M., Chen, G., McCormick, T. S., Cooper, K. D., Ghannoum, M.
(2004). Inhibition of Monocytic Interleukin-12 Production by Candida albicans via Selective Activation of ERK Mitogen-Activated Protein Kinase. Infect. Immun.
72: 2513-2520
[Abstract]
[Full Text]
-
Romagnoli, G., Nisini, R., Chiani, P., Mariotti, S., Teloni, R., Cassone, A., Torosantucci, A.
(2004). The interaction of human dendritic cells with yeast and germ-tube forms of Candida albicans leads to efficient fungal processing, dendritic cell maturation, and acquisition of a Th1 response-promoting function. J. Leukoc. Biol.
75: 117-126
[Abstract]
[Full Text]